Evidence map›Paper›PMID 33352971›Full record

ArticleCancers2020

Alan Aitchison, Christopher Hakkaart, Robert C Day, Helen R Morrin, Frank A Frizelle, Jacqueline I Keenan

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Muons, mutations, and planetary shielding.Frontiers in astronomy and space sciences · 2022
    Article
  11. Wnt/β-catenin signaling in cancers and targeted therapies.Signal transduction and targeted therapy · 2021
    Review
  12. Novel Mutation inDiagnostics (Basel, Switzerland) · 2021
    Article
  13. Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Alan AitchisonDepartment of Surgery, University of Otago Christchurch, Christchurch 8011, New Zealand.ORCID 0000-0002-0857-1815
Christopher HakkaartMackenzie Cancer Research Group, Department of Pathology and Biomedical Science, University of Otago Christchurch, Christchurch 8011, New Zealand.ORCID 0000-0001-5007-2684
Robert C DayDepartment of Biochemistry, University of Otago, Dunedin 9054, New Zealand.
Helen R MorrinCancer Society Tissue Bank, University of Otago Christchurch, Christchurch 8011, New Zealand.
Frank A FrizelleDepartment of Surgery, University of Otago Christchurch, Christchurch 8011, New Zealand.ORCID 0000-0002-0739-4802
Jacqueline I KeenanDepartment of Surgery, University of Otago Christchurch, Christchurch 8011, New Zealand.
University of Otago · NZCancer Society of New Zealand · NZ

Funding

University of Otago ORG 0119-0320
6 · The paper itself

Abstract

While overall colorectal cancer (CRC) cases have been declining worldwide there has been an increase in the incidence of the disease among patients under 50 years of age. Mutation of the

Indexed as

APCcolorectal cancerdietDNA methylationearly-onsetsequencing

Identifiers

PMID33352971
PMCPMC7766084
OpenAlexW3110683164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.